医药与保健
醫藥與保健
의약여보건
Medicine and Health Care
2015年
8期
102-103
,共2页
2型糖尿病%胰岛素泵%二甲双胍%阿卡波糖
2型糖尿病%胰島素泵%二甲雙胍%阿卡波糖
2형당뇨병%이도소빙%이갑쌍고%아잡파당
Type 2 diabetes mellitus%Insulin pump%Metformin%Acarbose
目的:探讨胰岛素泵联合二甲双胍、阿卡波糖与单纯胰岛素泵强化治疗对2型糖尿病的临床疗效及安全性。方法将100例2型糖尿病患者随机分为胰岛素泵联合二甲双胍、阿卡波糖治疗组(A组)和胰岛素泵治疗组(B组),连续治疗2周后评价两组临床疗效。结果强化治疗后,两组空腹血糖及餐后两小时血糖均明显下降。A组空腹血糖、餐后两小时血糖比B组控制更佳。A组血糖达标人数多于B组,血糖达标时间较B组提前,胰岛素日用量少于B组,胰岛素停用人数多于B组。A组出现低血糖反应人数明显少于B组,两组比较有显著性差异(P<0.05)。结论胰岛素泵联合二甲双胍治疗、阿卡波糖治疗2型糖尿病比单纯胰岛素泵能更好地控制血糖,减少胰岛素需求,减少低血糖发生,安全性更高。
目的:探討胰島素泵聯閤二甲雙胍、阿卡波糖與單純胰島素泵彊化治療對2型糖尿病的臨床療效及安全性。方法將100例2型糖尿病患者隨機分為胰島素泵聯閤二甲雙胍、阿卡波糖治療組(A組)和胰島素泵治療組(B組),連續治療2週後評價兩組臨床療效。結果彊化治療後,兩組空腹血糖及餐後兩小時血糖均明顯下降。A組空腹血糖、餐後兩小時血糖比B組控製更佳。A組血糖達標人數多于B組,血糖達標時間較B組提前,胰島素日用量少于B組,胰島素停用人數多于B組。A組齣現低血糖反應人數明顯少于B組,兩組比較有顯著性差異(P<0.05)。結論胰島素泵聯閤二甲雙胍治療、阿卡波糖治療2型糖尿病比單純胰島素泵能更好地控製血糖,減少胰島素需求,減少低血糖髮生,安全性更高。
목적:탐토이도소빙연합이갑쌍고、아잡파당여단순이도소빙강화치료대2형당뇨병적림상료효급안전성。방법장100례2형당뇨병환자수궤분위이도소빙연합이갑쌍고、아잡파당치료조(A조)화이도소빙치료조(B조),련속치료2주후평개량조림상료효。결과강화치료후,량조공복혈당급찬후량소시혈당균명현하강。A조공복혈당、찬후량소시혈당비B조공제경가。A조혈당체표인수다우B조,혈당체표시간교B조제전,이도소일용량소우B조,이도소정용인수다우B조。A조출현저혈당반응인수명현소우B조,량조비교유현저성차이(P<0.05)。결론이도소빙연합이갑쌍고치료、아잡파당치료2형당뇨병비단순이도소빙능경호지공제혈당,감소이도소수구,감소저혈당발생,안전성경고。
Objective To compare the effectiveness of insulin pump combining with metformin and acarbose to intensive insulin therapy for patients with type 2 diabetes mellitus.Methods 100 patients with type 2 diabetes melIitus were divided into randomly receive insulin pump combining with metformin and acarbose group (n=50) (Group A) or intensive insulin therapy group (n=50) (Group B).Results Both groups’FPG and 2h PG lowered obviously. But Group A’s FPG and 2h PG controlled better than Group B in number, time and insulin usage. Patients with reactive hypoglycemia in Group A was also less than Group B. Conclusion In treatment of type 2 diabetes mellitus, insulin pump combining with metformin and acarbose is better than intensive insulin therapy. It could control blood sugar better, reduce insulin usage and avoid reactive hypoglycemia distinctly.